is an innovative diagnostic platform that leverages smartphones to analyze and quantify test results with speed and precision. The specialized app evaluates and quantifies lateral flow tests with remarkable accuracy, offering rapid and cost-effective results for various diagnostic tests, including point-of-care testing for congenital hypothyroidism (CHT) in infants in resource-limited settings, as well as assessing thyroid levels, cortisol, and infectious diseases in biofluids. The platform is compatible with most smartphones, enabling test readings anywhere and anytime without the need for traditional lab equipment or electrical power. Founded in 2011, i-calQ operates in the Health Care and Information Technology industries. Although details about the company's headquarters, last investment, and investors are not available, the potential for leveraging existing smartphones for diagnostic purposes presents an intriguing opportunity for growth and impact in the healthcare sector. This innovative approach aligns with the increasing trend of leveraging mobile technology for healthcare solutions, making i-calQ a company to watch for potential investment opportunities.
Taxonomy: diagnostic platform, smartphone technology, point-of-care testing, lateral flow tests, medical diagnostics, quantitative analysis, biofluid analysis, POC diagnostics, Thyroid testing, congenital hypothyroidism, innovative technology, mobile healthcare, biomedical devices, digital health
